PF-3512676

· Pfizer

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for PF-3512676, covering 2009-09-28 to 2015-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer. [Phase 2]